DOSISPHERE-01: An Innovative Trial Design
Professor Etienne Garin discusses the innovative DOSISPHERE trial design. The trial uniquely performs randomization after the screening angiography, ensuring only eligible patients are included. It also introduces a strategy to spare at least 30% of the liver from radiation, allowing increased treatment activity without raising toxicity.